Detailed information for compound 218891

Basic information

Technical information
  • TDR Targets ID: 218891
  • Name: 3-(2-methylpiperidin-1-yl)propyl 4-cyclohexyl oxybenzoate
  • MW: 359.502 | Formula: C22H33NO3
  • H donors: 0 H acceptors: 1 LogP: 5.23 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC1CCCCN1CCCOC(=O)c1ccc(cc1)OC1CCCCC1
  • InChi: 1S/C22H33NO3/c1-18-8-5-6-15-23(18)16-7-17-25-22(24)19-11-13-21(14-12-19)26-20-9-3-2-4-10-20/h11-14,18,20H,2-10,15-17H2,1H3
  • InChiKey: YLRNESBGEGGQBK-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 3-(2-methyl-1-piperidyl)propyl 4-(cyclohexoxy)benzoate
  • 4-(cyclohexoxy)benzoic acid 3-(2-methyl-1-piperidinyl)propyl ester
  • 4-(cyclohexoxy)benzoic acid 3-(2-methylpiperidino)propyl ester
  • cyclomethycaine
  • 4-(cyclohexoxy)benzoic acid 3-(2-methyl-1-piperidyl)propyl ester
  • 139-62-8
  • Benzoic acid, p-(cyclohexyloxy)-, 3-(2-methylpiperidino)propyl ester
  • Cainasurfa
  • Ciclometicaina [INN-Spanish]
  • Cyclomethycainum [INN-Latin]
  • Surfacaine
  • Surfathesin
  • Topocaine
  • 1-Piperidinepropanol, 2-methyl-, p-(cyclohexyloxy)benzoate (ester)
  • 3-(2-Methylpiperidino)-propyl-p-cyclohexyloxybenzoate
  • 4-20-00-01466 (Beilstein Handbook Reference)
  • BRN 0293510
  • Benzoic acid, 4-(cyclohexyloxy)-, 3-(2-methyl-1-piperidinyl)propyl ester

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens sodium channel, voltage-gated, type I, alpha subunit Starlite/ChEMBL References
Homo sapiens jun proto-oncogene Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Leishmania infantum calcium channel protein, putative,ion transporter, putative Get druggable targets OG5_126819 All targets in OG5_126819
Echinococcus multilocularis jun protein Get druggable targets OG5_131442 All targets in OG5_131442
Brugia malayi bZIP transcription factor family protein Get druggable targets OG5_131442 All targets in OG5_131442
Leishmania major calcium channel protein, putative,ion transporter, putative Get druggable targets OG5_126819 All targets in OG5_126819
Echinococcus multilocularis sodium channel protein Get druggable targets OG5_126819 All targets in OG5_126819
Echinococcus granulosus jun protein Get druggable targets OG5_131442 All targets in OG5_131442
Echinococcus granulosus sodium channel protein Get druggable targets OG5_126819 All targets in OG5_126819
Leishmania donovani calcium channel protein, putative Get druggable targets OG5_126819 All targets in OG5_126819
Echinococcus granulosus voltage gated sodium channel Nav1 alpha subunit Get druggable targets OG5_126819 All targets in OG5_126819
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_131442 All targets in OG5_131442
Echinococcus granulosus Basic leucine zipper bZIP transcription factor Get druggable targets OG5_131442 All targets in OG5_131442
Leishmania braziliensis calcium channel protein, putative,ion transporter, putative Get druggable targets OG5_126819 All targets in OG5_126819
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription factor Get druggable targets OG5_131442 All targets in OG5_131442
Leishmania mexicana calcium channel protein, putative,ion transporter, putative Get druggable targets OG5_126819 All targets in OG5_126819
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus granulosus Basic leucine zipper bZIP transcription factor 0.0101 1 0.5
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription factor 0.0101 1 0.5
Schistosoma mansoni jun-related protein 0.0082 0.1276 0.5
Echinococcus granulosus jun protein 0.0101 1 0.5
Schistosoma mansoni hypothetical protein 0.0082 0.1276 0.5
Onchocerca volvulus 0.008 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0099 0.8724 0.5
Echinococcus multilocularis jun protein 0.0101 1 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 2 uM Inhibition of binding of Batrachotoxinin [3H]-BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex ChEMBL. 2579237
IC50 (binding) = 2 uM Inhibition of binding of Batrachotoxinin [3H]-BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex ChEMBL. 2579237
Inhibition (binding) = 81.9 % Inhibition of binding of Batrachotoxinin [3H]-BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex at 10 microM ChEMBL. 2579237
Inhibition (binding) = 81.9 % Inhibition of binding of Batrachotoxinin [3H]-BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex at 10 microM ChEMBL. 2579237
Potency (functional) 18.9959 uM PubChem BioAssay: Tox21. qHTS assay to identify small molecule agonists of the AP-1 signaling pathway. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.